Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Interest Expenses (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Interest Expenses data on record, last reported at $13.5 million in Q3 2025.

  • For Q3 2025, Interest Expenses fell 2.12% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $32.7 million, changed N/A, while the annual FY2025 figure was $56.9 million, 13.65% up from the prior year.
  • Interest Expenses reached $13.5 million in Q3 2025 per CAI's latest filing, down from $19.2 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $19.2 million in Q2 2025 and bottomed at $13.5 million in Q3 2025.